Roberto Corti mainly investigates Internal medicine, Myocardial infarction, Cardiology, Surgery and Endocrinology. The various areas that Roberto Corti examines in his Myocardial infarction study include Sirolimus, Bone marrow and Hazard ratio. Within one scientific family, Roberto Corti focuses on topics pertaining to Magnetic resonance imaging under Cardiology, and may sometimes address concerns connected to Computed tomography and Coronary artery calcification.
His research in Surgery intersects with topics in Coronary artery disease and Percutaneous coronary intervention. His Endocrinology research is multidisciplinary, incorporating elements of Brain natriuretic peptide and Neprilysin. His Revascularization study combines topics from a wide range of disciplines, such as Reperfusion therapy and Drug-eluting stent.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Surgery, Myocardial infarction and Magnetic resonance imaging. His Internal medicine study frequently draws connections to other fields, such as Endocrinology. His research on Cardiology frequently links to adjacent areas such as Bone marrow.
His study in the field of Revascularization also crosses realms of Peripheral blood mononuclear cell. His Magnetic resonance imaging study deals with Thrombus intersecting with Thrombosis. As a part of the same scientific study, Roberto Corti usually deals with the Endothelium, concentrating on Inflammation and frequently concerns with Pathology.
His scientific interests lie mostly in Cardiology, Internal medicine, Surgery, MitraClip and Myocardial infarction. Ejection fraction, Aortic valve, Regurgitation, Percutaneous coronary intervention and Transcatheter aortic are the primary areas of interest in his Cardiology study. His work deals with themes such as Natriuretic peptide and Mitral valve repair, which intersect with Ejection fraction.
His is involved in several facets of Internal medicine study, as is seen by his studies on Treatment outcome, Cardiac catheterization, Mace, Heart failure and New York Heart Association Class. Roberto Corti focuses mostly in the field of Surgery, narrowing it down to matters related to Atrial fibrillation and, in some cases, Amputation, Catheter, Culprit and Blood flow. His studies in Myocardial infarction integrate themes in fields like Stent, Magnetic resonance imaging and Bone marrow.
His primary areas of study are Internal medicine, Cardiology, Myocardial infarction, Surgery and MitraClip. His work in Stroke, Regurgitation, Heart failure, Transcatheter aortic and Odds ratio are all subfields of Internal medicine research. His Cardiology research is multidisciplinary, relying on both Fluoroscopy, Radiology and Prosthesis.
Roberto Corti interconnects Magnetic resonance imaging, Cardiac magnetic resonance imaging and Ejection fraction in the investigation of issues within Myocardial infarction. In his study, Bone marrow and Ventricle is inextricably linked to Natriuretic peptide, which falls within the broad field of Surgery. His MitraClip study combines topics in areas such as Radiation dose, Philips healthcare and Catheter manipulation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
Volker Schächinger;Sandra Erbs;Albrecht Elsässer;Werner Haberbosch.
The New England Journal of Medicine (2006)
Atherothrombosis and high-risk plaque: part I: evolving concepts.
Valentin Fuster;Pedro R. Moreno;Zahi A. Fayad;Roberto Corti.
Journal of the American College of Cardiology (2005)
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
Stephan Windecker;Andrea Remondino;Franz R. Eberli;Peter Jüni.
The New England Journal of Medicine (2005)
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker;Patrick Serruys;Simon Wandel;Pawel Buszman.
The Lancet (2008)
Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging
Roberto Corti;Zahi A. Fayad;Valentin Fuster;Stephen G. Worthley.
High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men
Lukas E. Spieker;Isabella Sudano;David Hürlimann;Peter G. Lerch.
Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging.
Roberto Corti;Valentin Fuster;Zahi A. Fayad;Stephen G. Worthley.
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
Christian Besler;Kathrin Heinrich;Lucia Rohrer;Carola Doerries.
Journal of Clinical Investigation (2011)
Cocoa and cardiovascular health.
Roberto Corti;Andreas J. Flammer;Norman K. Hollenberg;Thomas F. Lüscher.
MitraClip® therapy in patients with end-stage systolic heart failure.
Olaf Franzen;Jan van der Heyden;Stephan Baldus;Michael Schlüter.
European Journal of Heart Failure (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: